Literature DB >> 18641930

[Multimodal therapy of prostate cancer - 2 case reports].

Michael Lamche1, Wilhelm A Bauer, Paul Schramek.   

Abstract

The importance of the carcinoma of the prostate is still increasing. It is important to have options such as multimodal therapy. In this article two selected case reports are presented. Treatment options such as surgery, hormonal and irradiation therapy as well as chemotherapy will be discussed. Each patient suffering from carcinoma of prostate should receive individual best therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641930     DOI: 10.1007/s10354-008-0555-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  5 in total

1.  Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome.

Authors:  G Janetschek; A Hobisch; R Peschel; A Hittmair; G Bartsch
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

2.  Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low-stage testis cancer.

Authors:  J J Rassweiler; T Frede; E Lenz; O Seemann; P Alken
Journal:  Eur Urol       Date:  2000-03       Impact factor: 20.096

3.  Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update.

Authors:  Sam B Bhayani; Albert Ong; William K Oh; Philip W Kantoff; Louis R Kavoussi
Journal:  Urology       Date:  2003-08       Impact factor: 2.649

4.  The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.

Authors:  Agostino Mattei; Frank G Fuechsel; Nivedita Bhatta Dhar; Sebastian H Warncke; George N Thalmann; Thomas Krause; Urs E Studer
Journal:  Eur Urol       Date:  2007-08-03       Impact factor: 20.096

5.  Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience.

Authors:  Hannes Steiner; Reinhard Peschel; Günter Janetschek; Lorenz Höltl; Andreas P Berger; Georg Bartsch; Alfred Hobisch
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.